Acesso livre
Acesso livre

Hematologia Geral

Estudo randomizado | Tratamento precoce de pacientes ambulatoriais com plasma convalescente reduz o risco de internação para pacientes com Covid-19.

1 Abr, 2022 | 12:30h

Early Outpatient Treatment for Covid-19 with Convalescent Plasma – New England Journal of Medicine

Comentários:

Study finds convalescent plasma can be effective early COVID-19 therapy – Johns Hopkins University School of Medicine

Early Use of High-Titer Plasma Reduced COVID Hospitalizations— Randomized trial that influenced indication shows benefits in a mostly unvaccinated population – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

 


Estudo de coorte retrospectiva | Riscos de anafilaxia com formulações intravenosas de ferro.

31 Mar, 2022 | 13:19h

Risks for Anaphylaxis With Intravenous Iron Formulations: A Retrospective Cohort Study – Annals of Internal Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: Risk of Severe Allergic Reaction Higher with Two Intravenous Iron-Boosting Products – Rutgers University

Comentário: Risks for Anaphylaxis Compared Among IV Iron Products – HealthDay


Consenso multidisciplinar para o tratamento do tromboembolismo pulmonar.

29 Mar, 2022 | 14:59h

Multidisciplinary consensus for the management of pulmonary thromboembolism – Archivos de Bronconeumología


Recomendações de consenso | Tratamento da trombocitopenia imune.

29 Mar, 2022 | 14:56h

Management of immune thrombocytopenia: 2022 update of Korean experts recommendations – Blood Research


Estudo randomizado | Efeitos da transfusão de hemácias recém-irradiadas vs. irradiadas e armazenadas sobre a oxigenação cerebral de prematuros.

29 Mar, 2022 | 14:50h

Effects of Freshly Irradiated vs Irradiated and Stored Red Blood Cell Transfusion on Cerebral Oxygenation in Preterm Infants: A Randomized Clinical Trial – JAMA Pediatrics (gratuito por tempo limitado)

Editorial: Use of Irradiated Red Blood Cell Transfusions in Newborns to Improve Intracerebral Saturation – JAMA Pediatrics (gratuito por tempo limitado)

 

Comentário no Twitter

 


Estudo randomizado | Entre pacientes críticos com Covid-19, o tratamento com um agente antiplaquetário teve pouca propensão a melhorar os dias sem suporte de órgão em 21 dias.

24 Mar, 2022 | 12:33h

Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Thromboinflammation and Antithrombotics in COVID-19: Accumulating Evidence and Current Status – JAMA

Comentário: Aspirin may improve 3-month survival for patients critically ill with COVID-19 – Imperial College London

 

Comentários no Twitter

 


Diretrizes sobre doença falciforme | Prevenção secundária de AVC em crianças e adolescentes.

23 Mar, 2022 | 11:47h

Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira – 2022 – Hematology, Transfusion and Cell Therapy

Conteúdo relacionado: RCT: In children with sickle cell anemia, hydroxyurea in moderate doses (20 mg/kg per day) is not better than low doses (10 mg/kg per day) for primary stroke prevention.


Debate Pró-Con | Transfusão sanguínea pré-hospitalar – deveria ser adotada para traumas em civis?

22 Mar, 2022 | 11:37h

Pro-Con Debate: Prehospital Blood Transfusion—Should It Be Adopted for Civilian Trauma? – Anesthesia & Analgesia

Infográfico: Pre-Hospital Blood Transfusion: A Pro-Con Debate – Anesthesia & Analgesia

Conteúdo relacionado: RCT: In patients with trauma-related hemorrhagic shock receiving prehospital care, there was no benefit from resuscitation with blood products compared to 0.9% sodium chloride.


Terapia genética com valoctocogene roxaparvovec para hemofilia A.

22 Mar, 2022 | 11:28h

Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comentários:

Valoctocogene Roxaparvovec Evaluated in Severe Hemophilia A – HealthDay

Hemophilia A Gene Therapy Reduced Bleeding Events, Need for Clotting Factors – AJMC


Diretriz | Manejo de anticoagulantes e antiplaquetários durante sangramento gastrintestinal agudo e período periendoscópico.

21 Mar, 2022 | 16:38h

American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period – Journal of the Canadian Association of Gastroenterology

 

Comentário no Twitter

 


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.